Behavioral Health Business September 12, 2023
Several behavioral health executives shared their thoughts on the Drug Enforcement Administration’s (DEA) proposed rules for controlled substances and telehealth on Tuesday, with most going to bat for virtual-prescribing practices in front of agency officials.
Tuesday brought the first of two listening sessions to discuss what potential post-COVID regulations for telehealth prescribing could and should look like.
The DEA posted notice of the two-day listening session at the beginning of August and solicited comments about how the agency should resume regulating telehealth and the prescribing of certain controlled substances.
The discussion launched a novel approach for the DEA. It has, for the first time, reversed its stonewalling of a special registration process for telehealth prescribing of controlled substances. Further, the...
Today's Sponsors
Today's Sponsor